MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$4,022,763
Net Income
-$2,905,473
Net Profit Margin
-72.23%
EPS
-$0.22
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
4,022,763
2,639,353
1,571,922
1,180,534
Cost of revenue
1,444,592
872,862
792,427
678,977
Gross profit
2,578,171
1,766,491
779,495
501,557
Advertising and marketing
546,603
391,047
182,121
229,651
Professional fees
-
528,155
378,487
316,393
Professional fee
708,117
-
-
-
Officer compensation
22,500
22,500
22,500
22,500
Depreciation and amortization expense
90,810
97,694
98,343
76,078
Investor relations
25,000
21,500
15,000
25,000
General and administrative
619,164
475,812
389,319
277,696
Total operating expenses
2,012,194
1,536,708
1,085,770
947,318
Income (loss) from operations
565,977
229,783
-306,275
-445,761
Interest expense
2,233,797
2,190,549
2,007,597
3,490,962
Change in derivative liabilities
-1,237,653
1,084,492
921,030
-865
Gain on extinguishment of debt
-
-
-2
-416,155
Total other expense
-3,471,450
-1,106,057
-1,086,569
-3,907,980
Net loss
-2,905,473
-876,274
-1,392,843
-4,353,741
Basic EPS
-0.22
-0.07
-0.108
-0.35
Diluted EPS
-0.22
-0.07
-0.108
-0.35
Basic Average Shares
13,224,682
13,138,968
12,920,336
12,538,968
Diluted Average Shares
13,224,682
13,138,968
12,920,336
12,538,968
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Revenue
$4,022,763
(309.02%↑ Y/Y)
Gross profit
$2,578,171
(340.09%↑ Y/Y)
Cost of revenue
$1,444,592
(263.25%↑ Y/Y)
Net loss
-$2,905,473
(-122.51%↓ Y/Y)
Income (loss) from
operations
$565,977
(326.31%↑ Y/Y)
Total operating
expenses
$2,012,194
(140.72%↑ Y/Y)
Total other expense
-$3,471,450
(-228.83%↓ Y/Y)
Professional fee
$708,117
General and
administrative
$619,164
(198.47%↑ Y/Y)
Advertising and marketing
$546,603
(270.31%↑ Y/Y)
Depreciation and
amortization expense
$90,810
(65.61%↑ Y/Y)
Investor relations
$25,000
(-37.50%↓ Y/Y)
Officer compensation
$22,500
(0.00%↑ Y/Y)
Interest expense
$2,233,797
(111.66%↑ Y/Y)
Change in derivative
liabilities
-$1,237,653
(-377233.23%↓ Y/Y)
Buy us a coffee
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)